PAI-1 promoter polymorphism modulates uPA-PAI complex accumulation by breast cancer cells

Oncology

Volumn 62, Issue 3, 2002, Pages 286-290

  Alvarez Millan J J ^a   Bocos, C ^a   Ferrin V ^a   Lucas, A R ^b   Ruibal, A ^b   Schneider, J ^b,c  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b Fundacion Tejerina   (Spain)

^c Breast Pathology Center   (Spain)

Author keywords

Breast; Cancer; PAI 1; Polymorphism; Promoter

Indexed keywords

DNA; PLASMINOGEN ACTIVATOR INHIBITOR; UROKINASE;

ALLELE; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GRADING; CELL MEMBRANE TRANSPORT; CELLULAR DISTRIBUTION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA EXTRACTION; DNA POLYMORPHISM; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION;

BREAST NEOPLASMS; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; IMMUNOENZYME TECHNIQUES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036281559     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000059577     Document Type: Article

References (11)

1. Plasminogen activators, tissue degradation, and cancer
2. The urokinase-type plasminogen activator system in cancer metastasis: A review
3. Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer
4. Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse
5. Cellular accumulation of uPA-PAI-1 and uPA-PAI-2 complexes in early (pT1) breast cancer: A new link in the uPA-uPAr-PAI chain
6. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction
7. Characterisation of plasminogen activators secreted by human malignant cells
8. An alternative method for PAI-1 promoter polymorphism (4G/5G) typing
9. Sample preparation from paraffin-embedded tissues
10. Determination of the complex between urokinase and its type-1 inhibitor in plasma from healthy donors and breast cancer patients
11. The complex between urokinase and its type-1 inhibitor in primary breast cancer: Relation to survival